Smitaa Patel

Medicine & Life Sciences

1. Parkinson Disease 100%
2. Randomized Controlled Trials 44%
3. Language Therapy 40%
4. Speech Therapy 37%
5. Angioplasty 31%
6. Quality of Life 31%
7. Ischemia 30%
8. Balloon Angioplasty 29%
9. Levodopa 29%
10. Cost-Benefit Analysis 27%
11. Leg 23%
12. Extremities 23%
13. Monoamine Oxidase Inhibitors 22%
14. Monoamine Oxidase 19%
15. Dopamine Agonists 19%
16. Therapeutics 16%
17. Costs and Cost Analysis 16%
18. Random Allocation 15%
19. Rehabilitation 14%
20. Amputation 14%
21. Placebos 14%
22. Occupational Therapy 13%
23. Deep Brain Stimulation 13%
24. Survival 12%
25. Clinical Trials 12%
26. Quality-Adjusted Life Years 12%
27. Education 11%
28. Safety 11%
29. propylene diquat 10%
30. nabilone 9%
31. Observational Studies 8%
32. Pragmatic Clinical Trials 8%
33. Veins 8%
34. Systematic Reviews 8%
35. Speech Intelligibility 7%
36. Metals 7%
37. Catechol O-Methyltransferase 7%
38. Pseudotumor Cerebri 7%
39. Pharmaceutical Preparations 7%
40. Activities of Daily Living 7%
41. Confidence Intervals 7%
42. Shoulder Pain 6%
43. Cost of Illness 6%
44. Continuous Positive Airway Pressure 6%
45. Pressure Ulcer 6%
46. Meta-Analysis 6%
47. Health Care Outcome Assessment 6%
48. Huntington Disease 6%
49. Sleep Wake Disorders 6%
50. Delayed Diagnosis 6%